1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Percheron Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy ATL1102 25mg, ATL1102 50mg, Placebo - Duchenne Muscular Dystrophy | Phase 2 | Terminated | Percheron Therapeutics | 48 | 2023-05-18 | 2025-02-03 |
Muscular Dystrophy, Duchenne (1)
Australia (1) · Bulgaria (1) · Serbia (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Thomas Voit (1)